Waltering KK - Search Results

1

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.

Urbanucci A, Sahu B, Seppälä J, Larjo A, Latonen LM, Waltering KK, Tammela TL, Vessella RL, Lähdesmäki H, Jänne OA, Visakorpi T. Urbanucci A, et al. Among authors: waltering kk. Oncogene. 2012 Apr 26;31(17):2153-63. doi: 10.1038/onc.2011.401. Epub 2011 Sep 12. Oncogene. 2012. PMID: 21909140

2

Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.

Makkonen H, Jääskeläinen T, Pitkänen-Arsiola T, Rytinki M, Waltering KK, Mättö M, Visakorpi T, Palvimo JJ. Makkonen H, et al. Among authors: waltering kk. Oncogene. 2008 Aug 21;27(36):4865-76. doi: 10.1038/onc.2008.125. Epub 2008 May 12. Oncogene. 2008. PMID: 18469865

3

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.

Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T. Jalava SE, et al. Among authors: waltering kk. Oncogene. 2012 Oct 11;31(41):4460-71. doi: 10.1038/onc.2011.624. Epub 2012 Jan 23. Oncogene. 2012. PMID: 22266859

4

Screening of genetic and expression alterations of SRC1 gene in prostate cancer.

Mäki HE, Waltering KK, Wallén MJ, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Visakorpi T. Mäki HE, et al. Among authors: waltering kk. Prostate. 2006 Sep 15;66(13):1391-8. doi: 10.1002/pros.20427. Prostate. 2006. PMID: 16894533

5

Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.

Waltering KK, Wallén MJ, Tammela TL, Vessella RL, Visakorpi T. Waltering KK, et al. Prostate. 2006 Nov 1;66(15):1585-91. doi: 10.1002/pros.20387. Prostate. 2006. PMID: 16927275

6

MicroRNA expression profiling in prostate cancer.

Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. Porkka KP, et al. Among authors: waltering kk. Cancer Res. 2007 Jul 1;67(13):6130-5. doi: 10.1158/0008-5472.CAN-07-0533. Cancer Res. 2007. PMID: 17616669

7

Androgen regulation of the androgen receptor coregulators.

Urbanucci A, Waltering KK, Suikki HE, Helenius MA, Visakorpi T. Urbanucci A, et al. Among authors: waltering kk. BMC Cancer. 2008 Aug 1;8:219. doi: 10.1186/1471-2407-8-219. BMC Cancer. 2008. PMID: 18673534 Free PMC article.

8

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T. Waltering KK, et al. Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6. Cancer Res. 2009. PMID: 19808968

9

Androgen regulation of micro-RNAs in prostate cancer.

Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G, Visakorpi T. Waltering KK, et al. Prostate. 2011 May;71(6):604-14. doi: 10.1002/pros.21276. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945501

10

Androgen receptor (AR) aberrations in castration-resistant prostate cancer.

Waltering KK, Urbanucci A, Visakorpi T. Waltering KK, et al. Mol Cell Endocrinol. 2012 Sep 5;360(1-2):38-43. doi: 10.1016/j.mce.2011.12.019. Epub 2012 Jan 8. Mol Cell Endocrinol. 2012. PMID: 22245783 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page